Evidence map›Paper›PMID 34275134›Full record

ArticleThe Medical journal of Australia2021

The landscape of COVID-19 trials in Australia.

Anna Lene Seidler, Mason Aberoumand, Jonathan G Williams, Aidan Tan, Kylie E Hunter, Angela Webster

Abstract read
In one paragraph

Article in The Medical journal of Australia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. The response of Canada's clinical health research ecosystem to the COVID-19 pandemic.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2024
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. In the future simulations will replace clinical trials.Physical and engineering sciences in medicine · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna Lene SeidlerNHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.ORCID 0000-0002-0027-1623
Mason AberoumandNHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.
Jonathan G WilliamsNHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.ORCID 0000-0002-2878-0999
Aidan TanNHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.
Kylie E HunterNHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.
Angela WebsterNHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AustraliaClinical Trials as TopicCOVID-19HumansRegistriesClinical trials as topicCOVID-19Datasets as topicRegistries

Identifiers

PMID34275134
PMCPMC8447014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.